The Valley Desk

NCT04150497 · Interventional trial

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions B-cell Acute Lymphoblastic Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov